The clinical implications of COVID-19 have changed since SARS-CoV-2 first emerged in
humans. The current high levels of population immunity, due to prior infection and/or …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has had a major global
impact on solid organ transplantation (SOT). An estimated 16% global reduction in …

Background Illness after infection with the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) Omicron variant is less severe compared with previous variants. Data on the …

Solid organ transplant recipients (SOTRs) are at risk for severe coronavirus disease 2019
(COVID-19) infection because of immunosuppressive medications and comorbidities. 1, 2 …

Estimating the total coronavirus disease 2019 (COVID-19) mortality burden of solid organ
transplant recipients (SOTRs), both directly through COVID-19 infection and indirectly …

Major changes have occurred in therapeutics for coronavirus-19 (COVID-19) infection over
the past 12–18 mo, most notably in early outpatient therapy. In most cases, solid organ …

Abstract Purpose Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus type 2 (SARS-CoV-2) is currently the major threat for …

Background Clinical effectiveness of coronavirus disease 2019 (COVID‐19) vaccination in
solid organ transplant recipients (SOTRs) is not well documented despite multiple studies …

Solid organ transplant (SOT) recipients are at high risk for severe disease with severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Emerging variants of concern …

Abstract Purpose Lung transplant (LTx) recipients are at risk for poor outcomes from
coronavirus disease 2019 (COVID-19). The aim of the study was to assess the outcome of …